{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:55:35Z","timestamp":1763830535247},"reference-count":19,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.3892\/etm.2013.880","type":"journal-article","created":{"date-parts":[[2013,1,2]],"date-time":"2013-01-02T12:47:13Z","timestamp":1357130833000},"page":"912-916","source":"Crossref","is-referenced-by-count":13,"title":["Increasing gastric juice pH level prior to anti-Helicobacter pylori therapy may be beneficial to the healing of duodenal ulcers"],"prefix":"10.3892","volume":"5","author":[{"given":"HONG-YUN","family":"FAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUAN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUO-CHAO","family":"YAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAO-HUI","family":"HUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LI-JUAN","family":"MU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIAN-KUN","family":"CHU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WEI-WEI","family":"NIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHI-YING","family":"DUAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIN-CHENG","family":"MA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JING","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHI-YU","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,1,2]]},"reference":[{"key":"key20180108121637_b1-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(11)60020-2","article-title":"Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial","volume":"377","author":"Malfertheiner","year":"2011","journal-title":"Lancet"},{"key":"key20180108121637_b2-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"key":"key20180108121637_b3-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(09)60938-7","article-title":"Peptic ulcer disease","volume":"374","author":"Malfertheiner","year":"2009","journal-title":"Lancet"},{"key":"key20180108121637_b4-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"key20180108121637_b5-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/bega.1999.0055","article-title":"Conceivable mechanisms by which Helicobacter pylori provokes duodenal ulcer disease","volume":"14","author":"Olbe","year":"2000","journal-title":"Bailli\u00e8res Best Prac Res Clin Gastroenterol"},{"key":"key20180108121637_b6-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-0711-9-13","article-title":"Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial","volume":"9","author":"Bago","year":"2010","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"key20180108121637_b7-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"186734","DOI":"10.5402\/2012\/186734","article-title":"Helicobacter pylori Eradication Therapy: Current Availabilities","volume":"2012","author":"Gasparetto","year":"2012","journal-title":"ISRN Gastroenterol"},{"key":"key20180108121637_b8-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s005350070019","article-title":"Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor","volume":"35","author":"Kaneko","year":"2000","journal-title":"J Gastroenterol"},{"key":"key20180108121637_b9-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0934-8840(97)80052-7","article-title":"IgG and IgA antibodies in Helicobacter pylori infections","volume":"286","author":"Go\u015bciniak","year":"1997","journal-title":"Zentralbl Bakteriol"},{"key":"key20180108121637_b10-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/jcp.43.6.511","article-title":"Comparison of ELISA antigen preparations alone or in combination for serodiagnosing Helicobacter pylori infections","volume":"43","author":"Hirschl","year":"1990","journal-title":"J Clin Pathol"},{"key":"key20180108121637_b11-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/gut.27.6.642","article-title":"Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia","volume":"27","author":"Rathbone","year":"1986","journal-title":"Gut"},{"key":"key20180108121637_b12-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0934-8840(11)80958-8","article-title":"Helicobacter pylori antibodies in sera of children suffering from chronic abdominal pain","volume":"280","author":"Go\u015bciniak","year":"1993","journal-title":"Zentralbl Bakteriol"},{"key":"key20180108121637_b13-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/jac\/48.5.738","article-title":"Effect of pH on the susceptibility of Helicobacter pylori to the ketolide telithromycin (HMR 3647) and clarithromycin","volume":"48","author":"Lascols","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"key20180108121637_b14-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180108121637_b15-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/fmb.10.39","article-title":"Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces","volume":"5","author":"Corth\u00e9sy","year":"2010","journal-title":"Future Microbiol"},{"key":"key20180108121637_b16-etm-05-03-0912","first-page":"807","article-title":"Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis","volume":"55","author":"Manojlovic","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"key20180108121637_b17-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s100960000288","article-title":"Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy","volume":"19","author":"Heep","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key20180108121637_b18-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2036.2000.00795.x","article-title":"High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong","volume":"14","author":"Wang","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180108121637_b19-etm-05-03-0912","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1248\/cpb.59.553","article-title":"Stabilization mechanism of clarithromycin tablets under gastric pH conditions","volume":"59","author":"Fujiki","year":"2011","journal-title":"Chem Pharm Bull (Tokyo)"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2013.880\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T21:32:56Z","timestamp":1515447176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2013.880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,2]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,1,2]]},"published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.3892\/etm.2013.880"],"URL":"https:\/\/doi.org\/10.3892\/etm.2013.880","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,2]]}}}